Wellington Management Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.5M Buy
3,049,904
+1,475,579
+94% +$19.5M 0.01% 786
2026
Q1
$21.7M Buy
1,574,325
+184,603
+13% +$2.78M ﹤0.01% 979
2025
Q4
$25.1M Buy
1,389,722
+129,532
+10% +$2.33M ﹤0.01% 957
2025
Q3
$23.4M Buy
+1,260,190
New +$19.8M ﹤0.01% 963

Other funds holding CLBT

Wellington Management Group's CLBT Position: Q2 2026 in Review

Wellington Management Group increased its Cellebrite (CLBT) stake by 94% in Q2 2026, buying an estimated $19.5M and bringing the position to 3,049,904 shares worth $44.5M. The position accounts for 0.01% of the portfolio, ranked #786.

Wellington Management Group first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Wellington Management Group held 3,049,904 shares of Cellebrite worth $44.5M as of Q2 2026.
  • Wellington Management Group bought 1,475,579 Cellebrite shares in Q2 2026, an estimated $19.5M.
  • Cellebrite made up 0.01% of Wellington Management Group's portfolio in Q2 2026, its #786 holding.
  • Wellington Management Group first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.